K B Hahm
Overview
Explore the profile of K B Hahm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
677
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
An J, Kang E, Han Y, Kim Y, Hong Y, Hah B, et al.
J Physiol Pharmacol
. 2019 Oct;
70(3).
PMID: 31566193
Stress-related mucosal disease (SRMD), or stress ulceration, is a group of conditions ranging from stress-related superficial gastric mucosal damage to deep gastric ulcers that are primarily correlated with mucosal ischemia,...
2.
Han Y, Park J, Kangwan N, Jeong M, Lee S, Cho J, et al.
J Physiol Pharmacol
. 2015 Apr;
66(2):159-67.
PMID: 25903947
Gastrin is the main hormone stimulating gastric acid secretion, but it exerts proliferative and anti-apoptotic actions on various cancer cell types, in addition to its well-known trophic effect on enterochromaffin-like...
3.
Han Y, Park J, Park S, Hahm K, Hong S, Kim E
J Physiol Pharmacol
. 2013 Oct;
64(4):429-37.
PMID: 24101389
Increased serum gastrin concentrations in patients with colorectal cancer suggested the tumorigenic trophic effect of gastrin. Detailed and global molecular mechanisms explaining trophic effect of gastrin had not been revealed....
4.
Park S, Hong H, Han Y, Kangwan N, Kim S, Kim E, et al.
J Physiol Pharmacol
. 2013 Jun;
64(2):157-65.
PMID: 23756390
Gastrointestinal or cardiovascular complications limit nonsteroidal anti-inflammatory drugs (NSAID) prescription. Glucosamine hydrochloride (GS-HCl) alternatively chosen, but debates still exist in its clinical efficiency. COX-2 instability through inhibiting COX-2 N-glycosylation of...
5.
Choi S, Lee S, Kim Y, Ok C, Lee H, Hahm K
J Physiol Pharmacol
. 2010 Apr;
60 Suppl 7:5-17.
PMID: 20388941
With the discovery of gastric acid and pepsin in the stomach, the questions about "why does the stomach not digest itself?", "how does the stomach preserve its normal integrity under...
6.
Oh T, Ryu B, Ko J, Ahn B, Kim S, Kim W, et al.
Arch Pharm Res
. 2008 Nov;
20(5):414-9.
PMID: 18982482
Gastrointestinal irritation is the most frequent adverse effect in patients chronically taking nonsteroidal antiinflammatory drugs (NSAIDs) for the treatment of arthritic conditions. Gastroprotective effect of DA-9601, a new antiulcer agent...
7.
Hahm K, Kim D, Lee K, Lee J, Surh Y, Kim Y, et al.
Aliment Pharmacol Ther
. 2003 Aug;
18 Suppl 1:24-38.
PMID: 12925138
Background: It has been suggested that chronic, persistent, uncontrolled inflammations in the stomach could provide the basic step for the beginning of carcinogenesis. One of the potential clinical applications of...
8.
Kim D, Kim S, Song Y, Oh T, Han S, Kim Y, et al.
Aliment Pharmacol Ther
. 2003 Aug;
18 Suppl 1:14-23.
PMID: 12925137
Background: Long-term evaluation of gastric pathology after H. pylori infection is very important in order to reveal its clinical implications, since debate still exists on the gastric carcinogenesis provoked by...
9.
Lee K, Cho S, Kim S, Kim H, Hahm K, Kim J
J Viral Hepat
. 2002 May;
9(3):208-12.
PMID: 12010509
Lamivudine-induced HBeAg seroconversion may not be durable in Korean patients with hepatitis B virus (HBV) infection. It is unknown whether virological response during lamivudine treatment affects the post-treatment outcome. We...
10.
Choi K, Lee Y, Chung I, Lee J, Chung M, Kim N, et al.
Dig Dis Sci
. 2002 Feb;
47(2):283-91.
PMID: 11855542
Production of cytokines along with increased activity of nitric oxide synthase has been implicated as one of the contributing mechanisms of Helicobacter pylori-mediated gastroduodenal diseases. We aimed to evaluate the...